Lightnews — Scholar-powered news

Emilie Gunn

@emiliemgunn.bsky.social

130 followers 150 following 32 posts

Journals Director @ ASCO, President @ Council of Science Editors, mom, reader, cook, knitter, Girl Scouts leader, runner, general lover of words. All views are mine.

Posts Media Videos Starter Packs

Emilie Gunn @emiliemgunn.bsky.social · 5d

@councilscienceed.bsky.social (CSE) is offering our virtual Short Course on Pub Management on 10/31/25. The agenda is full of everything you need to know to make your publication the best it can be.

15% off if you also reg for the CSE Fall Symposium!

www.councilscienceeditors.org/short-courses

www.councilscienceeditors.org

Reposted by Emilie Gunn

JCO Journals @jco-asco.bsky.social · 19d

We're thrilled to be here on BlueSky to bring you the latest practice-changing oncology research from all six JCO Journals! Follow-us for great content from #JCO, #JCOOP, #JCOGO, #JCOPO, #JCOCCI, & #JCOOA.

Emilie Gunn @emiliemgunn.bsky.social · Aug 20

Now available!! 🎧

Listen in to JCO OP's latest podcast, Promoting Resilience in Adolescents and Young Adults (AYAs) with Cancer via Developmentally Targeted, Evidence-Based Interventions | Podcast | ASCO Publications ascopubs.org/do/promoting...

Promoting Resilience in Adolescents and Young Adults (AYAs) with Cancer via Developmentally Targeted, Evidence-Based Interventions | Podcast | ASCO Publications

An estimated 85k adolescents and young adults (AYAs) between the ages of 15 to 39 will be diagnosed with cancer in the United States this year. AYAs with advanced cancer face care gaps for psychosocia...

Emilie Gunn @emiliemgunn.bsky.social · Jul 1

Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income Countries | JCO Global Oncology ascopubs.org/doi/10.1200/...

Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income Countries | JCO Global Oncology

The growing cancer burden and suboptimal diagnostic capacity in low- and middle-income countries calls for urgent innovation in diagnostic solutions. Point-of-care technologies (POCTs) offer a transfo...

Emilie Gunn @emiliemgunn.bsky.social · Jun 18

Listen to the latest JCO Oncology Practice podcast, in which @fumikochino.bsky.social discusses barriers to cancer care that seem minor (e.g. paying for park) but are definitely not. ascopubs.org/do/park-park...

Park the Parking: Patient and Caregiver Perspectives on Transportation Barriers in Cancer | Podcast | ASCO Publications

Frustrations regarding the costs and difficulties with parking at hospitals is a common concern voiced by patients, families, and healthcare providers. Transportation barriers to receiving cancer care...

Emilie Gunn @emiliemgunn.bsky.social · May 31

Stay connected to JCO Journals during #ASCO25! www.asco.org/annual-meeti...

JCO Central - ASCO

Reposted by Emilie Gunn

Kathy D Miller, MD @kathydmillermd.bsky.social · May 31

Stop by JCO central while at ASCO. Enjoy the coffee, meet the editors and staff, learn more about JCO

Emilie Gunn @emiliemgunn.bsky.social · May 31

Simultaneous Publication in #JCOOP. #ASCO25

Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...

Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial | JCO Oncology Practice

PURPOSEMedical podcast integration into hematology/oncology fellowship curricula remains largely unstudied. We conducted a multicenter cluster randomized trial to evaluate the educational impact of a ...

Emilie Gunn @emiliemgunn.bsky.social · May 31

If you didn't hang out in JCO Central, did you even really attend #ASCO25?

Come join us for some great events in S403b!

Reposted by Emilie Gunn

American Society of Clinical Oncology @ascocancer.bsky.social · May 30

‼️ #ASCO25 simultaneous publication by Jacobs et al: 

BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...

Emilie Gunn @emiliemgunn.bsky.social · May 30

Read all about it! Simultaneous Publication out now in JCO:

BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...

BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation

PURPOSEFamily and friend caregivers of patients undergoing hematopoietic stem-cell transplantation (HSCT) struggle with immense caregiving burden, leading to substantial quality of life (QOL) impairme...

Reposted by Emilie Gunn

American Society of Clinical Oncology @ascocancer.bsky.social · May 29

Psst ... want to see how we're brewing up #ASCO25? We're busy behind the scenes making sure everything's just right! Can't WAIT to officially open the doors, welcome everyone, and get this Annual Meeting party started! See you there!

Emilie Gunn @emiliemgunn.bsky.social · May 23

Pregnancy and Breast Cancer | Podcast | ASCO Publications ascopubs.org/do/pregnancy...

Pregnancy and Breast Cancer | Podcast | ASCO Publications

Dr. Chino talks with Dr. Erin Roesch and patient advocate Julia Maues about pregnancy associated cancer with a focus on breast cancer, the most common cancer diagnosed during pregnancy. This discussio...

Emilie Gunn @emiliemgunn.bsky.social · May 22

Time to Treatment Initiation for the 30 Most Prevalent Cancer Types: Trends and Predictors of Change | JCO Oncology Practice ascopubs.org/doi/10.1200/...

Time to Treatment Initiation for the 30 Most Prevalent Cancer Types: Trends and Predictors of Change | JCO Oncology Practice

PURPOSEAs the complexity and need for cancer care services continue to grow, time to treatment initiation (TTI) has been increasing across cancer types. Presently there are no comprehensive analyses i...

Reposted by Emilie Gunn

Jeremy Warner, MD, MS, FAMIA, FASCO @hemoncwarner.bsky.social · May 20

Use of Large Language Models in Clinical Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10....

ASCO Publications

Emilie Gunn @emiliemgunn.bsky.social · Apr 28

And an editorial from Editor in Chief Pamela Kunz, MD: ascopubs.org/doi/10.1200/...

Trials in Progress: The Power of Timely Cancer Clinical Trial Communication | JCO Oncology Advances

Emilie Gunn @emiliemgunn.bsky.social · Apr 28

📣 Have something to report on an ongoing clinical trial? #JCOOA now accepting Trials in Progress articles! Read the first one here:

SWOG 2308: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low–Tumor Burden Follicular Lymphoma ascopubs.org/doi/10.1200/...

SWOG 2308: Randomized Phase III Study of Mosunetuzumab Versus Rituximab for Low–Tumor Burden Follicular Lymphoma | JCO Oncology Advances

Emilie Gunn @emiliemgunn.bsky.social · Apr 24

In the latest episode of JCO OP: Put Into Practice, @fumikochino.bsky.social talks with Dr. Atif Khan and Dr. Lola Fayanju about treatment de-escalation in patients with breast cancer.
ascopubs.org/do/treatment...

Treatment De-escalation for Favorable Risk Breast Cancer | Podcast | ASCO Publications

Dr. Chino talks with Dr. Atif Khan and Dr. Lola Fayanju about the shift in breast cancer management from reducing locoregional recurrence and improving breast cancer mortality to deintensification, sh...

Emilie Gunn @emiliemgunn.bsky.social · Apr 11

Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...

Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial | JCO Oncology Practice

PURPOSEThe purpose ot this study was to assess the effectiveness of an educational video compared to in-person genetic counseling for cancer genetic testing candidates. Genetic cancer risk assessment ...

Reposted by Emilie Gunn

Satan’s Niece @krissychula.bsky.social · Apr 6

This is high art

Reposted by Emilie Gunn

Council of Science Editors @councilscienceed.bsky.social · Mar 25

Navigating a change from self-publishing, independent publishing, or a commercial publisher can be tenuous and fraught. Join Adam Etkin and Susan Willner at 12 PM ET as we discuss how to plan for an effective publisher move! Register NOW: www.councilscienceeditors.org/cse-connect

Emilie Gunn @emiliemgunn.bsky.social · Mar 21

Early Bird registration is ending soon for the @councilscienceed.bsky.social annual meeting. Join us in Minneapolis May 3-6!

Council of Science Editors @councilscienceed.bsky.social · Mar 20

Planning to join us from May 3-6 in Minneapolis? Time is running out for you to get the best deal! Register before March 31 to secure Early Bird Pricing 🐦

Before you book your travel, check out the schedule to see all #CSEMinneapolis has to offer: cse.memberclicks.net/annual-meeti...

Emilie Gunn @emiliemgunn.bsky.social · Mar 21

Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert Recommendations | JCO Clinical Cancer Informatics ascopubs.org/doi/10.1200/...

Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert Recommendations | JCO Clinical Cancer Informatics

PURPOSETo determine the accuracy of large language models (LLMs) in generating appropriate treatment options for patients with early breast cancer on the basis of their medical records.MATERIALS AND M...

Emilie Gunn @emiliemgunn.bsky.social · Mar 20

🎙️In the latest #JCOOP podcast, @fumikochino.bsky.social discusses the past, present, and future of prior authorization in cancer care with Dr. Michael Anne Kyle, a health policy expert with a research focus on utilization management and patient burdens from prior auth. 🎧
ascopubs.org/do/prior-aut...

Prior Authorization: How Did We Get Here and Where Are We Going? | ASCO Publications

Dr. Chino discusses the past, present, and future of prior authorization in cancer care with Dr. Michael Anne Kyle, a health policy expert with a research focus on utilization management and patient b...

Emilie Gunn @emiliemgunn.bsky.social · Mar 18

Phase II Evaluation of Ultra-Hypofractionated Postoperative Radiation Therapy for Breast Cancer: Toxicity and Efficacy in a Single-Center Nonrandomized Prospective Study | JCO Global Oncology ascopubs.org/doi/10.1200/...

Phase II Evaluation of Ultra-Hypofractionated Postoperative Radiation Therapy for Breast Cancer: Toxicity and Efficacy in a Single-Center Nonrandomized Prospective Study | JCO Global Oncology

PURPOSETo evaluate the toxicity profile and efficacy of postoperative ultra-hypofractionated radiation therapy in elderly patients with breast cancer.MATERIALS AND METHODSThis is a nonrandomized, sing...